Get started
Work

Rationale and Design of the ATHENA-HF Trial

Year: 2016
Type: article
Study design: Study Protocol
DOI: 10.1016/j.jchf.2016.06.003
Authors: Javed Butler, Adrian F. Hernandez, Kevin J. Anstrom, Andreas Kalogeropoulos, Margaret M. Redfield, Marvin A. Konstam, W.H. Wilson Tang, G. Michael Felker, Monica R. Shah, Eugene Braunwald
Institutions: Stony Brook Medicine, Stony Brook University, Duke University, Emory University, Mayo Clinic, Tufts University, Cleveland Clinic, National Heart, Lung, and Blood Institute, Brigham and Women's Hospital, Harvard University
Language: English
Field: Medicine
Open Access status: bronze
Funders: American Heart Association, Amgen, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, American College of Cardiology Foundation, Gilead Sciences, Thoratec Corporation, Cytokinetics, ResMed, National Institutes of Health, National Heart, Lung, and Blood Institute
Awards: G1190857639, G148474664, G1752053572, G1922218243, Heart Failure Clinical Research Network, G2649805311, G3090663733, G3173312616, G4275022512, G440667919, G4502176547, Gene- and Cell-based therapies for LVAD patients, Partners Heart Failure Network, G5427893961, G5632795586, G5865313147, Heart Failure Clinical Trials Network, G68134748, G7207483343, G723595051, Heart Failure Clinical Research Network Regional Clinical Center (U10), G8602860650, G889217082, G9000025672, G9000084725, G9000090027, G9000118039, G9000125311, G9000312920, G9000323280, G9000340410
OpenAlex ID: W2509537460
FWCI: 5.226
Cites: 48
Cited by: 37
Related to: 10